SE0101773D0 - Novel compounds - Google Patents
Novel compoundsInfo
- Publication number
- SE0101773D0 SE0101773D0 SE0101773A SE0101773A SE0101773D0 SE 0101773 D0 SE0101773 D0 SE 0101773D0 SE 0101773 A SE0101773 A SE 0101773A SE 0101773 A SE0101773 A SE 0101773A SE 0101773 D0 SE0101773 D0 SE 0101773D0
- Authority
- SE
- Sweden
- Prior art keywords
- sub
- ring
- phenyl
- novel compounds
- compounds
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 3
- 125000001072 heteroaryl group Chemical group 0.000 abstract 2
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 208000018522 Gastrointestinal disease Diseases 0.000 abstract 1
- 208000027520 Somatoform disease Diseases 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 125000001246 bromo group Chemical group Br* 0.000 abstract 1
- 125000001309 chloro group Chemical group Cl* 0.000 abstract 1
- 125000004122 cyclic group Chemical group 0.000 abstract 1
- 125000001153 fluoro group Chemical group F* 0.000 abstract 1
- 125000002541 furyl group Chemical group 0.000 abstract 1
- 125000002883 imidazolyl group Chemical group 0.000 abstract 1
- 125000002346 iodo group Chemical group I* 0.000 abstract 1
- 208000027753 pain disease Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- ILVXOBCQQYKLDS-UHFFFAOYSA-N pyridine N-oxide Chemical compound [O-][N+]1=CC=CC=C1 ILVXOBCQQYKLDS-UHFFFAOYSA-N 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 125000000168 pyrrolyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 125000000335 thiazolyl group Chemical group 0.000 abstract 1
- 125000001544 thienyl group Chemical group 0.000 abstract 1
- 125000001425 triazolyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Hydrogenated Pyridines (AREA)
Priority Applications (23)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0101773A SE0101773D0 (sv) | 2001-05-18 | 2001-05-18 | Novel compounds |
| CZ20033093A CZ20033093A3 (cs) | 2001-05-18 | 2002-05-16 | 4-[Fenyl(piperidin-4-yl)amino]benzamidové deriváty a jejich použití pro ošetřování bolesti, úzkosti nebo gastrointestinálních poruch |
| JP2002591458A JP2005508291A (ja) | 2001-05-18 | 2002-05-16 | ４−（フェニル−（ピペリジン−４−イル）−アミノ）−ベンズアミド誘導体及び疼痛、不安症又は胃腸障害の治療のためのその使用 |
| SK1399-2003A SK13992003A3 (sk) | 2001-05-18 | 2002-05-16 | 4-(Fenyl(piperidin-4-yl)amino)benzamidové deriváty a ich požitie na liečbu bolesti, anxiety alebo gastrointestinálnych porúch |
| US10/477,636 US7008952B2 (en) | 2001-05-18 | 2002-05-16 | 4-(phenyl-(piperidin-4yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| BR0209665-0A BR0209665A (pt) | 2001-05-18 | 2002-05-16 | Composto, processo para preparar o mesmo, uso de um composto, composição farmacêutica, e, métodos para o tratamento da dor, de distúrbios gastrintestinais funcionais, e da ansiedade |
| CA002446516A CA2446516A1 (en) | 2001-05-18 | 2002-05-16 | 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| PCT/SE2002/000957 WO2002094785A1 (en) | 2001-05-18 | 2002-05-16 | 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| EP02733713A EP1395557A1 (en) | 2001-05-18 | 2002-05-16 | 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| EEP200300526A EE200300526A (et) | 2001-05-18 | 2002-05-16 | 4-(fenüül(piperidiin-4-üül)amino)bensamiidi derivaadid ja nende kasutamine valu, ärevuse või seedetrakti häirete raviks |
| IL15870002A IL158700A0 (en) | 2001-05-18 | 2002-05-16 | 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| PL02367246A PL367246A1 (en) | 2001-05-18 | 2002-05-16 | 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| ARP020101818A AR036231A1 (es) | 2001-05-18 | 2002-05-16 | Derivados de 4-diarilamino piperidina,procedimiento para su preparacion, empleo de estos derivados para la fabricacion de medicamentos, composicion farmaceutica y compuestos intermediarios |
| CNA028141687A CN1527818A (zh) | 2001-05-18 | 2002-05-16 | 4-(苯基-(哌啶-4-基)-氨基)-苯甲酰胺衍生物及其在治疗疼痛、焦虑症或胃肠病中的应用 |
| RU2003131963/04A RU2003131963A (ru) | 2001-05-18 | 2002-05-16 | Производные 4-(фенил-(пиперидин-4-ил)-амино)-бензамида и их применение для лечения боли, тревоги или желудочно-кишечных расстройств |
| MXPA03010444A MXPA03010444A (es) | 2001-05-18 | 2002-05-16 | Derivados de 4-(fenil-(piperidin-4-il)-amino)-benzamida y sus usos para tratamiento del dolor, ansiedad o trastornos gastrointestinales. |
| KR10-2003-7014951A KR20040000472A (ko) | 2001-05-18 | 2002-05-16 | 4-(페닐-(피페리딘-4-일)-아미노)-벤즈아미드 유도체 및통증,불안증 또는 위장관 장애의 치료를 위한 그의 용도 |
| HU0401610A HUP0401610A2 (hu) | 2001-05-18 | 2002-05-16 | 4-[Fenil-(4-piperidinil)-amino]-benzamid-származékok, alkalmazásuk, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények |
| ZA200308642A ZA200308642B (en) | 2001-05-18 | 2003-11-05 | 4-(Phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders. |
| BG108334A BG108334A (bg) | 2001-05-18 | 2003-11-07 | 4-(фенил-(пиперидин-4-ил)-амино)-бензамидни производни и тяхното използване за лечение на болка, потиснатост или стомашно-чревни разстройства |
| CO03100170A CO5540320A2 (es) | 2001-05-18 | 2003-11-12 | Derivados de 4-(fenil-(piperidin-4-il)-amino)benzamida y sus usos para el tratamiento del dolor, la ansiedad o desordenes gastrointestinales |
| IS7033A IS7033A (is) | 2001-05-18 | 2003-11-13 | 4-(fenýl-(píperidín-4-ýl)-amínó)-bensamíðafleiðurog notkun þeirra til meðhöndlunar á sársauka, kvíða eða truflunum í maga og þörmum |
| NO20035119A NO20035119D0 (no) | 2001-05-18 | 2003-11-17 | 4-(fenyl-(piperidin-4-yl)-amino)-benzamidderivater og deres anvendelse vedbehandling av angst, smerte eller gastrointestinale forstyrrelser |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0101773A SE0101773D0 (sv) | 2001-05-18 | 2001-05-18 | Novel compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE0101773D0 true SE0101773D0 (sv) | 2001-05-18 |
Family
ID=20284176
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE0101773A SE0101773D0 (sv) | 2001-05-18 | 2001-05-18 | Novel compounds |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US7008952B2 (enExample) |
| EP (1) | EP1395557A1 (enExample) |
| JP (1) | JP2005508291A (enExample) |
| KR (1) | KR20040000472A (enExample) |
| CN (1) | CN1527818A (enExample) |
| AR (1) | AR036231A1 (enExample) |
| BG (1) | BG108334A (enExample) |
| BR (1) | BR0209665A (enExample) |
| CA (1) | CA2446516A1 (enExample) |
| CO (1) | CO5540320A2 (enExample) |
| CZ (1) | CZ20033093A3 (enExample) |
| EE (1) | EE200300526A (enExample) |
| HU (1) | HUP0401610A2 (enExample) |
| IL (1) | IL158700A0 (enExample) |
| IS (1) | IS7033A (enExample) |
| MX (1) | MXPA03010444A (enExample) |
| NO (1) | NO20035119D0 (enExample) |
| PL (1) | PL367246A1 (enExample) |
| RU (1) | RU2003131963A (enExample) |
| SE (1) | SE0101773D0 (enExample) |
| SK (1) | SK13992003A3 (enExample) |
| WO (1) | WO2002094785A1 (enExample) |
| ZA (1) | ZA200308642B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ593444A (en) | 2003-10-01 | 2012-12-21 | Adolor Corp | 4-[(2-N,N-diethylaminocarbonyl)pyrid-5-yl]-spiro[1,2-dihydronaphthalene-2,4'-piperidine] and methods of its use |
| US7598261B2 (en) | 2005-03-31 | 2009-10-06 | Adolor Corporation | Spirocyclic heterocyclic derivatives and methods of their use |
| US7576207B2 (en) | 2006-04-06 | 2009-08-18 | Adolor Corporation | Spirocyclic heterocyclic derivatives and methods of their use |
| CN113979997A (zh) * | 2021-11-12 | 2022-01-28 | 中国科学院昆明植物研究所 | N,n-(4-哌啶基、芳基)-3-氨基苯酚类衍生物及其药物组合物和其应用 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4091096A (en) | 1976-03-19 | 1978-05-23 | Eli Lilly And Company | Dinitroanilines for the control of phytopathogens |
| EG12406A (en) | 1976-08-12 | 1979-03-31 | Janssen Pharmaceutica Nv | Process for preparing of novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides |
| US4252812A (en) | 1977-05-23 | 1981-02-24 | Pfizer Inc. | 2-Substituted-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indoles |
| SE441448B (sv) | 1977-05-23 | 1985-10-07 | Pfizer | Sett att framstella hexahydro-gamma-karbolinforeningar |
| DE3200304A1 (de) | 1981-01-16 | 1982-08-26 | Sandoz-Patent-GmbH, 7850 Lörrach | 3-aminopropoxyaryl-derivate, ihre herstellung und sie enthaltende arzneimittel |
| EP0181793B1 (fr) | 1984-10-16 | 1988-07-27 | Synthelabo | Dérivés de pipéridine, leur préparation et leur application en thérapeutique |
| YU150489A (sh) | 1989-08-10 | 1992-12-21 | W.L. Gore & Co. Gmbh. | Uređaj za ispitivanje odevnih predmeta na nepromočivost |
| KR940003491B1 (ko) | 1989-08-10 | 1994-04-23 | 리히터 게데온 베기에스제티 기아르 알.티 | 4,4-이중 치환된 피페리딘 유도체와 그 제조방법 및 상기 화합물을 함유하는 약제학적 조성물 |
| US5854245A (en) | 1996-06-28 | 1998-12-29 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
| TW548271B (en) * | 1996-12-20 | 2003-08-21 | Astra Pharma Inc | Novel piperidine derivatives having an exocyclic double bond with analgesic effects |
| SE9604786D0 (sv) | 1996-12-20 | 1996-12-20 | Astra Pharma Inc | New compounds |
| ZA9811842B (en) | 1997-12-24 | 2000-06-23 | Ortho Mcneil Pharm Inc | 4-[aryl(piperidin-4-yl)]aminobenzamides. |
| EP1061919A4 (en) | 1998-03-10 | 2002-09-04 | Res Triangle Inst | NOVEL OPIOUS COMPOUNDS AND PROCESSES FOR THEIR PREPARATION AND USE |
| SE9904675D0 (sv) * | 1999-12-20 | 1999-12-20 | Astra Pharma Inc | Novel compounds |
| EP1263758A2 (en) * | 2000-03-03 | 2002-12-11 | Ortho-McNeil Pharmaceutical, Inc. | 3-(diarylmethylene)-8-azabicyclo[3.2.1]octane derivatives |
| SE0001207D0 (sv) * | 2000-04-04 | 2000-04-04 | Astrazeneca Canada Inc | Novel compounds |
-
2001
- 2001-05-18 SE SE0101773A patent/SE0101773D0/xx unknown
-
2002
- 2002-05-16 HU HU0401610A patent/HUP0401610A2/hu unknown
- 2002-05-16 SK SK1399-2003A patent/SK13992003A3/sk unknown
- 2002-05-16 JP JP2002591458A patent/JP2005508291A/ja active Pending
- 2002-05-16 CN CNA028141687A patent/CN1527818A/zh active Pending
- 2002-05-16 KR KR10-2003-7014951A patent/KR20040000472A/ko not_active Withdrawn
- 2002-05-16 PL PL02367246A patent/PL367246A1/xx not_active Application Discontinuation
- 2002-05-16 MX MXPA03010444A patent/MXPA03010444A/es unknown
- 2002-05-16 RU RU2003131963/04A patent/RU2003131963A/ru not_active Application Discontinuation
- 2002-05-16 WO PCT/SE2002/000957 patent/WO2002094785A1/en not_active Ceased
- 2002-05-16 BR BR0209665-0A patent/BR0209665A/pt not_active Application Discontinuation
- 2002-05-16 CZ CZ20033093A patent/CZ20033093A3/cs unknown
- 2002-05-16 US US10/477,636 patent/US7008952B2/en not_active Expired - Fee Related
- 2002-05-16 CA CA002446516A patent/CA2446516A1/en not_active Abandoned
- 2002-05-16 EP EP02733713A patent/EP1395557A1/en not_active Withdrawn
- 2002-05-16 IL IL15870002A patent/IL158700A0/xx unknown
- 2002-05-16 EE EEP200300526A patent/EE200300526A/xx unknown
- 2002-05-16 AR ARP020101818A patent/AR036231A1/es not_active Application Discontinuation
-
2003
- 2003-11-05 ZA ZA200308642A patent/ZA200308642B/en unknown
- 2003-11-07 BG BG108334A patent/BG108334A/bg unknown
- 2003-11-12 CO CO03100170A patent/CO5540320A2/es not_active Application Discontinuation
- 2003-11-13 IS IS7033A patent/IS7033A/is unknown
- 2003-11-17 NO NO20035119A patent/NO20035119D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20040000472A (ko) | 2004-01-03 |
| RU2003131963A (ru) | 2005-05-10 |
| EP1395557A1 (en) | 2004-03-10 |
| BR0209665A (pt) | 2004-04-20 |
| NO20035119D0 (no) | 2003-11-17 |
| WO2002094785A1 (en) | 2002-11-28 |
| BG108334A (bg) | 2004-12-30 |
| AR036231A1 (es) | 2004-08-25 |
| JP2005508291A (ja) | 2005-03-31 |
| IS7033A (is) | 2003-11-13 |
| SK13992003A3 (sk) | 2004-04-06 |
| HUP0401610A2 (hu) | 2004-12-28 |
| CO5540320A2 (es) | 2005-07-29 |
| ZA200308642B (en) | 2005-02-07 |
| CN1527818A (zh) | 2004-09-08 |
| CA2446516A1 (en) | 2002-11-28 |
| US20040142966A1 (en) | 2004-07-22 |
| IL158700A0 (en) | 2004-05-12 |
| MXPA03010444A (es) | 2004-03-09 |
| US7008952B2 (en) | 2006-03-07 |
| PL367246A1 (en) | 2005-02-21 |
| CZ20033093A3 (cs) | 2004-07-14 |
| EE200300526A (et) | 2004-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2002094794A8 (en) | 4 (phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders | |
| SE0001207D0 (sv) | Novel compounds | |
| SE0101765D0 (sv) | Novel compounds | |
| SE0103313D0 (sv) | Novel compounds | |
| SE0101766D0 (sv) | Novel compounds | |
| SE0001209D0 (sv) | Novel compounds | |
| SE0001208D0 (sv) | Novel compounds | |
| SE0101768D0 (sv) | Novel compounds | |
| SE9904673D0 (sv) | Novel compounds | |
| BG106807A (en) | Novel compounds | |
| SE0101771D0 (sv) | Novel compounds | |
| SE0101769D0 (sv) | Novel compounds | |
| SE0101767D0 (sv) | Novel compounds | |
| SE0101770D0 (sv) | Novel compounds | |
| SE0101773D0 (sv) | Novel compounds | |
| SE0101772D0 (sv) | Novel compounds |